Milestone Scientific financials
$0.41000.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M | $5.4M | $8.4M | $9.6M | $11.3M | $10.5M |
| Gross profit | $6.4M | $6.4M | $6.8M | $4.9M | $6.3M | $3.6M | $5.7M | $4.4M | $7.0M | $6.3M |
| Gross margin | 71.4% | 74.6% | 69.1% | 55.7% | 61.3% | 66.6% | 68.3% | 46.1% | 61.8% | 60.2% |
| Operating income | -$5.7M | -$6.8M | -$7.1M | -$8.8M | -$7.4M | -$7.5M | -$4.0M | -$8.0M | -$5.2M | -$6.5M |
| Net income | -$5.7M | -$4.7M | -$6.9M | -$8.7M | -$6.8M | -$7.3M | -$7.5M | -$7.4M | -$5.2M | -$5.9M |
| Net margin | −63.8% | −54.6% | −70.5% | −98.9% | −66.2% | −134.9% | −89.8% | −77.2% | −46.0% | −56.7% |
| Diluted EPS | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 | $-0.12 | $-0.16 | $-0.21 | $-0.16 | $-0.22 |
| EBITDA | -$5.6M | -$6.7M | -$7.0M | -$8.8M | -$7.2M | -$7.4M | -$3.9M | -$5.6M | -$4.7M | -$6.4M |
| Operating cash flow | -$2.9M | -$2.9M | -$5.3M | -$6.0M | -$4.0M | -$7.0M | -$1.8M | -$1.6M | -$1.2M | -$5.4M |
| Free cash flow | -$2.9M | -$2.9M | -$5.3M | -$6.0M | -$4.0M | -$7.0M | -$1.8M | -$1.6M | -$1.2M | -$5.4M |
| Diluted shares | 82.1M | 79.8M | 72.8M | 70.6M | 68.8M | 63.1M | 45.7M | 35.3M | 32.7M | 27.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.1M | $3.3M | $3.0M | $8.7M | $14.8M | $14.2M |
| Short-term investments | $0.00 | $0.00 | $3.0M | $0.00 | — | — |
| Total debt | $854.7K | $67.2K | $10.7K | $20.1K | $28.6K | $312.6K |
| Total assets | $7.8M | $9.8M | $11.4M | $13.7M | $19.8M | $19.6M |
| Total liabilities | $5.0M | $4.0M | $3.4M | $3.7M | $3.6M | $3.5M |
| Shareholders' equity | $2.8M | $5.8M | $8.0M | $10.0M | $16.2M | $16.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology